Treatment of head and neck hemangiomas with recombinant interferon alpha 2B.

Abstract

Fifteen patients with head and neck hemangiomas were treated with systemic recombinant interferon alpha 2b (rIFNalpha2b, Schering). There were 14 infants and 1 adult in the group, ranging in age from 5 weeks to 24 years old. Of the 15 patients in the group, 5 had involvement of the airway. Three of the patients had previously failed alternative systemic… (More)

Topics

  • Presentations referencing similar topics